About Us
Based near Oxford, UK, Glide Pharma is developing a pipeline of Glide-branded, “supergeneric” products and is also co-developing products with a growing list of pharmaceutical and biotech partners, all based on its proprietary Glide technology. Glide SDI allows the injection of drugs, vaccines and other active pharmaceutical ingredients in a solid form. Glide SDI is an innovative new needle-free injection system that offers significant benefits and opportunities to drug developers, healthcare providers, patients and their carers.
Glide Pharma has an experienced Management Team and a strong Board of Directors who are focused on making Glide Pharma a leading manufacturer of pharmaceutical products and the partner of choice for pharmaceutical and biotechnology companies looking for the best drug delivery options for their products.
Glide Pharma conducts formulation development as well as manufacturing and supply of finished products, thus allowing partners to enter into relationships without large capital outlay during early clinical development. Glide Pharma formulates the partner’s drug into a solid dosage form suitable for injection with the needle-free Glide SDI technology. The ability to inject drugs as solids offers pharmaceutical companies a valuable new option for drug delivery, providing a stable, controllable and clean mechanism to deliver drugs and vaccines directly into the body’s tissues.
